ResearcherNanjing Drum Tower HospitalNo recent work listed
Meng Cao
Matched on ORCID iD 0000-0001-9166-2824; OpenAlex author ID A5101681948. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2019: 2 papers · 2020: 1 paper · 2021: 1 paper
Papers 4
- DUOX2 As a Potential Prognostic Marker which Promotes Cell Motility and Proliferation in Pancreatic Cancer. Co-author DOI 10.1155/2021/6530298↗
- A novel antisense lncRNA NT5E promotes progression by modulating the expression of SYNCRIP and predicts a poor prognosis in pancreatic cancer. First author DOI 10.1111/jcmm.15718↗
- The RNA m6A methyltransferase METTL3 promotes pancreatic cancer cell proliferation and invasion. Co-author DOI 10.1016/j.prp.2019.152666↗
- LncRNA BANCR Promotes Pancreatic Cancer Tumorigenesis via Modulating MiR-195-5p/Wnt/β-Catenin Signaling Pathway. Co-author DOI 10.1177/1533033819887962↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Guodong Shi · 4 shared papers, 2019–2021 · strength 0.39
- Paper DUOX2 As a Potential Prognostic Marker which Promotes Cell Motility and Proliferation in Pancreatic Cancer. DOI 10.1155/2021/6530298↗
- Paper A novel antisense lncRNA NT5E promotes progression by modulating the expression of SYNCRIP and predicts a poor prognosi… DOI 10.1111/jcmm.15718↗
- Paper The RNA m6A methyltransferase METTL3 promotes pancreatic cancer cell proliferation and invasion. DOI 10.1016/j.prp.2019.152666↗
- Pengbo Zhang · 4 shared papers, 2019–2021 · strength 0.39
- Paper DUOX2 As a Potential Prognostic Marker which Promotes Cell Motility and Proliferation in Pancreatic Cancer. DOI 10.1155/2021/6530298↗
- Paper A novel antisense lncRNA NT5E promotes progression by modulating the expression of SYNCRIP and predicts a poor prognosi… DOI 10.1111/jcmm.15718↗
- Paper The RNA m6A methyltransferase METTL3 promotes pancreatic cancer cell proliferation and invasion. DOI 10.1016/j.prp.2019.152666↗
- Baobao Cai · 4 shared papers, 2019–2021 · strength 0.39
- Paper DUOX2 As a Potential Prognostic Marker which Promotes Cell Motility and Proliferation in Pancreatic Cancer. DOI 10.1155/2021/6530298↗
- Paper A novel antisense lncRNA NT5E promotes progression by modulating the expression of SYNCRIP and predicts a poor prognosi… DOI 10.1111/jcmm.15718↗
- Paper The RNA m6A methyltransferase METTL3 promotes pancreatic cancer cell proliferation and invasion. DOI 10.1016/j.prp.2019.152666↗
- Kuirong Jiang · 4 shared papers, 2019–2021 · strength 0.39
- Paper DUOX2 As a Potential Prognostic Marker which Promotes Cell Motility and Proliferation in Pancreatic Cancer. DOI 10.1155/2021/6530298↗
- Paper A novel antisense lncRNA NT5E promotes progression by modulating the expression of SYNCRIP and predicts a poor prognosi… DOI 10.1111/jcmm.15718↗
- Paper The RNA m6A methyltransferase METTL3 promotes pancreatic cancer cell proliferation and invasion. DOI 10.1016/j.prp.2019.152666↗
- Zipeng Lu · 3 shared papers, 2019–2020 · strength 0.26
- Paper A novel antisense lncRNA NT5E promotes progression by modulating the expression of SYNCRIP and predicts a poor prognosi… DOI 10.1111/jcmm.15718↗
- Paper The RNA m6A methyltransferase METTL3 promotes pancreatic cancer cell proliferation and invasion. DOI 10.1016/j.prp.2019.152666↗
- Paper LncRNA BANCR Promotes Pancreatic Cancer Tumorigenesis via Modulating MiR-195-5p/Wnt/β-Catenin Signaling Pathway. DOI 10.1177/1533033819887962↗
- Tianfang Xia · 3 shared papers, 2019–2020 · strength 0.26
- Paper A novel antisense lncRNA NT5E promotes progression by modulating the expression of SYNCRIP and predicts a poor prognosi… DOI 10.1111/jcmm.15718↗
- Paper The RNA m6A methyltransferase METTL3 promotes pancreatic cancer cell proliferation and invasion. DOI 10.1016/j.prp.2019.152666↗
- Paper LncRNA BANCR Promotes Pancreatic Cancer Tumorigenesis via Modulating MiR-195-5p/Wnt/β-Catenin Signaling Pathway. DOI 10.1177/1533033819887962↗
- Xinquan Wu · 3 shared papers, 2019–2020 · strength 0.26
- Paper A novel antisense lncRNA NT5E promotes progression by modulating the expression of SYNCRIP and predicts a poor prognosi… DOI 10.1111/jcmm.15718↗
- Paper The RNA m6A methyltransferase METTL3 promotes pancreatic cancer cell proliferation and invasion. DOI 10.1016/j.prp.2019.152666↗
- Paper LncRNA BANCR Promotes Pancreatic Cancer Tumorigenesis via Modulating MiR-195-5p/Wnt/β-Catenin Signaling Pathway. DOI 10.1177/1533033819887962↗
- Yi Miao · 3 shared papers, 2019–2020 · strength 0.26
- Paper A novel antisense lncRNA NT5E promotes progression by modulating the expression of SYNCRIP and predicts a poor prognosi… DOI 10.1111/jcmm.15718↗
- Paper The RNA m6A methyltransferase METTL3 promotes pancreatic cancer cell proliferation and invasion. DOI 10.1016/j.prp.2019.152666↗
- Paper LncRNA BANCR Promotes Pancreatic Cancer Tumorigenesis via Modulating MiR-195-5p/Wnt/β-Catenin Signaling Pathway. DOI 10.1177/1533033819887962↗
- Shouji Cao · 2 shared papers, 2020–2021 · strength 0.21
- Qun Chen · 2 shared papers, 2020–2021 · strength 0.21
- Pengfei Wu · 2 shared papers, 2019–2021 · strength 0.21
- Lei Chen · 2 shared papers, 2019–2020 · strength 0.17
- Pengfei Wu · 2 shared papers, 2019–2020 · strength 0.17
- Jingjing Zhang · 2 shared papers, 2019 · strength 0.17
- Wanli Ge · 1 shared paper, 2021 · strength 0.12
- Yi Miao · 1 shared paper, 2021 · strength 0.12
- Lei Xu · 1 shared paper, 2020 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.